(Q43817365)

English

Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

author name string

J K Marshall

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J M Pellissier

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C L Attard

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S X Kong

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M A Marentette

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1039-1049

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200119100-00005

0 references

Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in arthritis patients using nonsteroidal anti-inflammatory drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of NSAID-induced gastropathy: an economic decision analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripherally acting analgesics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of misoprostol in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the medical management of osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of NSAID associated gastrointestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11735672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200119100-00005

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43817365&oldid=2103611996"